Latest Health News
US Government Revokes Greenhouse Gas Endangerment Finding
The Trump administration withdrew the 2009 EPA determination that greenhouse gas emissions endanger public health, potentially undermining emission standards and climate policy. This risks significant damage to health and livelihoods. Critics highlight its role in anchoring legal climate protections.
Calls for UK National Televised Emergency Briefing on Health Risks
A letter urges the UK Prime Minister and broadcasters for a televised briefing following a November emergency session, citing failure to inform the public on major issues. It demands public engagement on risks. Signatories emphasize broadcasters' obligations.
Airglove Medical Launches v2 for Difficult Venous Access
Scottish firm Airglove Medical unveiled Airglove v2, an air warming system enhancing vein dilation for easier cannulation, achieving 87.5% first-time success in oncology trials across UK hospitals. It reduces failures in 32 million annual UK procedures and improves patient comfort.
India's Ayurveda Market Reaches $20 Billion Milestone
India drives the world's fastest-growing traditional healthcare market with Ayurveda valued at $20 billion as of February 14, 2026. The sector highlights rapid expansion in alternative medicine globally.
Tandem 2026 Highlights EB-103 CAR-T 100% Response in NHL
EB-103, an ARTEMIS-based CD19 CAR-T, achieved 100% ORR/CR at recommended dose in aggressive B-cell NHL with only grade 1/2 CRS. It shows manufacturability in high-risk older patients.
KITE-753 Dual CAR-T Achieves 86% ORR in Lymphoma
KITE-753 dual CD19/CD20 CAR-T reported 86% ORR and 79% CR in CAR-naïve lymphoma, with no severe CRS/ICANS and 13-day manufacturing. This advances rapid, tolerable cellular therapy deployment.
Targeted Lead Isotope Radiation Promising for Colorectal Cancer
Preclinical studies test paired lead isotopes with engineered antibodies for precise radiation delivery to colorectal tumors, minimizing healthy tissue exposure. Imaging tracks distribution for dosing and safety.
Radioactive Trastuzumab Targets HER2-Positive Breast Cancer
Lab and mouse studies evaluate radioactive trastuzumab's tumor uptake, dosing, and efficacy against HER2-positive breast cancer compared to existing therapies. It assesses biodistribution and side effects.
Paul E. Farmer Maternal Center Opens February 14
The Paul E. Farmer Maternal Center of Excellence opens to its first patients on February 14, honoring the global health pioneer's legacy through maternal care initiatives. It realizes a longtime vision.
RMTS-CRISPR Breakthrough in Mitochondrial Gene Editing
Novel RMTS-CRISPR tool fuses components to deliver guide RNAs into mitochondria, overcoming key editing challenges. This advances CRISPR applications in mitochondrial diseases.
Tiny RNA QT45 Discovery Sheds Light on Life's Origins
MRC LMB researchers identified QT45, a small self-replicating RNA polymerase ribozyme, supporting spontaneous emergence of life via RNA world hypothesis. It copies itself and complements through lab evolution.
3rd London Health Tourism Expo Spotlights Global Care
The expo on February 14-15 at QEII Centre features 80+ hospitals, Türkiye prominent, for B2B and public info on international treatments. It aids comparisons amid rising patient demand.